New Zealand - English - Ministry for Primary Industries

vetoquinol new zealand limited - neomycin sulphate; nystatin; permethrin; triamcinolone acetonide - neomycin sulphate 5.15 g/litre; nystatin 21 g/litre; permethrin 10 g/litre; triamcinolone acetonide 1 g/litre - ectoparasiticide

Ireland - English - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - neomycin sulphate; nystatin; triamcinolone acetonide; permethrin (25:75) technical - gel - . - triamcinolone and antiinfectives - dogs - antibacterial

Canada - English - Health Canada

vetoquinol n a inc - permethrin; nystatin; neomycin sulfate; triamcinolone acetonide - ointment - 10mg; 100000unit; 3500unit; 1mg - permethrin 10mg; nystatin 100000unit; neomycin sulfate 3500unit; triamcinolone acetonide 1mg - cats

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

gladron chemicals sdn bhd - neomycin sulphate; nystatin; permethrin; triamcinolone acetonide -

Philippines - English - FDA (Food And Drug Administration)

agfield international corporation; distributor: agfield international corporation - permethrine / neomycin (as sulphate) / nystatin / triamcinolone (as acetonide) - ear ointment - 10 mg / 3500 iu / 100 000 iu / 0.908

Israel - English - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; clotrimazole; gentamicin (as sulfate) - cream - clotrimazole 10 mg/g; betamethasone as dipropionate 0.5 mg/g; gentamicin (as sulfate) 1 mg/g - corticosteroids, potent, other combinations - treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. the cream is suitable for the use of oozing eczema.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 59130 - dermal tissue reconstructive material, animal-derived - matriderm serves as a scaffold for tissue regeneration and modulates the formation of scar tissue. matriderm has excellent haemostyptic properties and thus reduces the risk of subgraft haematoma, for example,between the matrix and the wound bed. in addition, matriderm supports orderly healing and acts as a temporary adhesion barrier. matriderm is a three-dimensional matrix composed of native, structurally intact collagen fibrils and elastin. matriderm is used in combination with autologous split-thickness skin grafts for the reconstruction of deep dermal defects and full-thickness skin wounds in plastic reconstructive surgery and in the surgical treatment of burns, trauma and dermatological diseases. it may also be used in the treatment of poorly healing wounds requiring skin grafts (e.g. chronic wounds); for the reconstruction of mucosal defects and also under intact skin for the temporary separation of tissues, thereby preventing adherence, especially of tendons and their surrounding connective tissue, after injuries or surgical procedures. the aim of treatment with matriderm is to construct a neodermis,to improve the quality of reconstituted tissue, reduce scarring, prevent wound contraction and restore functionality.

Israel - English - Ministry of Health

trupharm marketing 1985 ltd. - inhalants,epidermal extracts - solution for injection - inhalants,epidermal extracts - insects - insects - skin testing and immunotherapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram